| Literature DB >> 28861646 |
Sergiu Cecoltan1, Izabela-Cristina Stancu2,3, Diana Maria Drăguşin1,4, Andrada Serafim1, Adriana Lungu1,4, Cătălin Ţucureanu5, Iuliana Caraş5, Vlad Constantin Tofan5, Aurora Sălăgeanu5, Eugeniu Vasile6, Romain Mallet7, Daniel Chappard7,8, Cristin Coman5, Mircea Istodorescu9, Horia Iovu1,10.
Abstract
Nano-apatite and gelatin-alginate hydrogel microparticles have been prepared by a one-step synthesis combined with electrostatic bead generation, for the reconstruction of bone defects. Based on the analysis of bone composition, architecture and embryonic intramembranous ossification, a bio-inspired fabrication has been developed. Accordingly, the mineral phase has been in situ synthesized, calcifying the hydrogel matrix while the latter was crosslinked, finally generating microparticles that can assemble into a bone defect to ensure interconnected pores. Although nano-apatite-biopolymer composites have been widely investigated, microstructural optimization to provide improved distribution and stability of the mineral is rarely achieved. The optimization of the developed method progressively resulted in two types of formulations (15P and 7.5P), with 15 and 7.5 (wt%) phosphate content in the initial precursor. The osteolytic potential was investigated using differentiated macrophages. A commercially available calcium phosphate bone graft substitute (Eurocer 400) was incorporated into the hydrogel, and the obtained composites were in vitro tested for comparison. The cytocompatibility of the microparticles was studied with mouse osteoblast-like cell line MC3T3-E1. Results indicated the best in vitro performance have been obtained for the sample loaded with 7.5P. Preliminary evaluation of biocompatibility into a critical size (3 mm) defect in rabbits showed that 7.5P nanocomposite is associated with newly formed bone in the proximity of the microparticles, after 28 days.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28861646 DOI: 10.1007/s10856-017-5966-8
Source DB: PubMed Journal: J Mater Sci Mater Med ISSN: 0957-4530 Impact factor: 3.896